OPTIPEN Side Effects

6978927-6 | Hyperglycaemia, Metastases To Lung
on Sep 06, 2010 Male patient from BRAZIL , weighting 180.8 lb, was diagnosed with type 2 diabetes mellitus, prostatic disorder, glaucoma (What is glaucoma?) and was treated with Optipen (View Usage). Patient experienced the following unwanted or unexpected effects: hyperglycaemia, metastases to lung. Optipen dosage: . During the same period patient was treated with INSULIN GLARGINE (30-34 Iu Daily) (View Insulin Glargine Review and Insulin Glargine Label ), DETRUSITOL (View Detrusitol Review and Detrusitol Label ), CASODEX (View Casodex Review and Casodex Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ).

6775736-8 | Cataract, Cold Sweat, Dizziness, Feeling Abnormal, Heart Rate Increased, Hyperglycaemia, Hypoglycaemia, Hypoglycaemic Unconsciousness, Loss Of Consciousness
Patient was taking Optipen (View Usage). Patient had the following side effects: cataract (What is cataract?), cold sweat, dizziness (What is dizziness?), feeling abnormal, heart rate increased, hyperglycaemia, hypoglycaemia, hypoglycaemic unconsciousness, loss of consciousness on Jun 08, 2010 from BRAZIL Additional patient health information: Female patient , weighting 141.1 lb, was diagnosed with thyroid disorder and. Optipen dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), AUTOPEN 24 (View Autopen 24 Review and Autopen 24 Label ), HUMALOG (View Humalog Review and Humalog Label ), METFORMIN (Dose As Used: 1 Tab After Meals Dose Unit: 500 Mg) (View Metformin Review and Metformin Label ), GALVUS (View Galvus Review and Galvus Label ), PURAN T4 (Dose Unit: 50 Ug) (View Puran T4 Review and Puran T4 Label ).

6603692-1 | Hypoglycaemia, Road Traffic Accident
Adverse event was reported on Jan 28, 2010 by a Male patient taking Optipen (View Usage) (Dosage: ) . Location: SWITZERLAND , 43 years of age, After Optipen was administered, patient had the following side effects: hypoglycaemia, road traffic accident. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

6550119-4 | Hypoglycaemia, Road Traffic Accident
on Jan 12, 2010 Male patient from SWITZERLAND , 43 years of age, was treated with Optipen (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, road traffic accident. Optipen dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.


6502581-0 | Asthenia, Blood Glucose Increased, Coma, Device Misuse, Hyperhidrosis, Hypoglycaemia, Ketoacidosis, Overdose, Tremor
on Nov 25, 2009 Female patient from BRAZIL , 15 years of age, weighting 116.8 lb, was treated with Optipen (View Usage). Patient had the following side effects: asthenia, blood glucose increased, coma, device misuse, hyperhidrosis, hypoglycaemia, ketoacidosis, overdose, tremor. Optipen dosage: . During the same period patient was treated with INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ), HUMALOG (Dose As Used: 6 Iu At Breakfast,8 Iu At Lunch, 6 Iu For Snack (in The Afternoon) And 8 Iu At Dinner) (View Humalog Review and Humalog Label ). Patient was hospitalized.

6479947-0 | Blood Glucose Increased, Ketosis, Product Quality Issue
Patient was taking Optipen (View Usage). After Optipen was administered, patient had the following side effects: blood glucose increased, ketosis, product quality issue on Nov 15, 2009 from BRAZIL Additional patient health information: Female patient , 25 years of age, weighting 108.0 lb, was diagnosed with type 1 diabetes mellitus and. Optipen dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), HUMALOG (View Humalog Review and Humalog Label ).

6448533-0 | Asthenia, Blood Glucose Increased, Coma, Device Electrical Finding, Device Misuse, Hyperhidrosis, Hypoglycaemia, Ketoacidosis, Overdose
Adverse event was reported on Oct 22, 2009 by a Female patient taking Optipen (View Usage) (Dosage: ) . Location: BRAZIL , 15 years of age, weighting 116.8 lb, Patient experienced the following unwanted or unexpected effects: asthenia, blood glucose increased, coma, device electrical finding, device misuse, hyperhidrosis, hypoglycaemia, ketoacidosis, overdose. During the same period patient was treated with INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ), HUMALOG (Dose As Used: 6 Iu At Breakfast,8 Iu At Lunch, 6 Iu For Snack (in The Afternoon) And 8 Iu At Dinner) (View Humalog Review and Humalog Label ). Patient was hospitalized.